If the page does not redirect, click here
Treating triple negative breast cancer by targeting pair of receptorsAds from Inoreader • Remove
Triple negative breast cancer (TNBC) is a particularly aggressive form of breast cancer that lacks known targets for therapies, making it difficult to treat. However, a new study by a group of researchers and physician-scientists, led by Baylor College of Medicine, has identified a novel treatment strategy that may be effective for TNBC patients. The study appears in Nature Medicine.